Correction to: Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Metabolic Brain Disease October 1, 2021 Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli et al. 23 citations correction
Ayahuasca shows promise in enhancing mental health, with a notable increase in brain-derived neurotrophic factor (BDNF) levels by 50% among participants. In a study involving 100 individuals, 70% reported significant reductions in anxiety and depression after treatment. This psychedelic brew influences neurotransmitter receptors, potentially reshaping behavior and emotional well-being. The findings highlight its potential role in internal medicine and psychology, suggesting that ayahuasca could be a valuable tool in modern pharmacology and neurology, while maintaining low toxicity levels.